​

Spectral AI Stock (NASDAQ:MDAI)

RevenueOwnershipFinancialsChartTranscripts
Spectral AI by TradingView

Previous Close

$1.80

52W Range

$1.13 - $3.21

50D Avg

$1.55

200D Avg

$1.87

Market Cap

$58.56M

Avg Vol (3M)

$687.24K

Beta

0.91

Div Yield

-

MDAI Company Profile

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

78

IPO Date

Apr 06, 2021

Website

MDAI Performance

MDAI Financial Summary

Dec 25Dec 24Dec 23
Revenue$19.65M$29.58M$18.06M
Operating Income$-8.60M$-6.58M$-12.98M
Net Income$-7.57M$-15.31M$-20.85M
EBITDA$-7.97M$-11.49M$-20.12M
Basic EPS$-0.29$-0.85$-1.48
Diluted EPS$-0.29$-0.85$-1.48

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 24, 26 | 12:00 AM
Q3 25Nov 11, 25 | 5:00 PM
Q2 25Aug 13, 25 | 5:00 PM

Peer Comparison

TickerCompany
COEPCoeptis Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
EQEquillium, Inc.
ICCMIceCure Medical Ltd
TELATELA Bio, Inc.
SRTSSensus Healthcare, Inc.
CTSOCytosorbents Corporation
TELOTelomir Pharmaceuticals, Inc. Common Stock
KPTIKaryopharm Therapeutics Inc.
ECORelectroCore, Inc.